Imaging of the liver, biliary tract, and pancreas.
The interaction between the various noninvasive and invasive imaging modalities used to evaluate the liver, biliary tract, and pancreas is demonstrated in this article. By understanding this interaction and correlating noninvasive studies, the clinician will avoid diagnostic redundancy and the need for invasive testing may be reduced.
D000230:Adenocarcinoma / Q000175:diagnosis; D001660:Biliary Tract Diseases / Q000175:diagnosis*; D001707:Biopsy, Needle; D002758:Cholangiography; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000175:diagnosis / Q000000981:diagnostic imaging; D002779:Cholestasis / Q000175:diagnosis; D003937:Diagnosis, Differential; D006498:Hepatectomy; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging; D008107:Liver Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D010182:Pancreatic Diseases / Q000175:diagnosis*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging; D010195:Pancreatitis / Q000175:diagnosis; D011877:Radionuclide Imaging; D013154:Spleen / Q000000981:diagnostic imaging; D013671:Technetium Tc 99m Sulfur Colloid; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D013671:Technetium Tc 99m Sulfur Colloid